Samsung Biologics Co.,Ltd. (KRX:207940)
1,641,000
-39,000 (-2.32%)
At close: Dec 5, 2025
11.06% (1Y)
| Market Cap | 75.96T |
| Revenue (ttm) | 5.50T |
| Net Income (ttm) | 1.60T |
| Shares Out | 46.29M |
| EPS (ttm) | 34,474.63 |
| PE Ratio | 47.60 |
| Forward PE | 40.07 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 54,357 |
| Average Volume | 96,761 |
| Open | 1,667,000 |
| Previous Close | 1,680,000 |
| Day's Range | 1,640,000 - 1,677,500 |
| 52-Week Range | 1,396,083 - 1,944,983 |
| Beta | 0.16 |
| RSI | 45.47 |
| Earnings Date | Jan 20, 2026 |